Next Generation Molecular Assay Market Outlook:
Next Generation Molecular Assay Market size was valued at USD 5.51 billion in 2025 and is set to exceed USD 9.23 billion by 2035, expanding at over 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of next generation molecular assay is estimated at USD 5.77 billion.
With the increasing technological advancements in the healthcare infrastructure, the demand for innovative early disease detection testing tools is growing simultaneously boosting the next generation molecular assay market.
Moreover, evolving advanced methods such as polymerase chain reaction are helpful in achieving precise detections compared to traditional detecting methods. Polymerase chain reaction excels in identifying genetic material responsible for infection. For instance, polymerase chain reaction tests helped in the detection of SARS-CoV-2 and rescued many patients from the infection at an early stage.
